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In this s tudy we show that both cultured normal hu-
man epidermal cells (EC) and a human squamous cell 
carcinoma (SCC) cell line produce a thymocyte-activat-
ing factor (ETAF). EC-ETAF and SCC-ETAF both have 
a Mr of 15,000 and were eluted from chromatofocusing 
at the same isoelectric points of 7 .2, 5 .8, and 5.0. Both 
activities were maintained at alkaline pH and were 
destroyed at temperatures above 60°C. In addition to 
stimulating thymocyte proliferation, human ET AF ex-
hibited a variety of other pertinent biologic activities. 
Although EC-ET AF or SCC-E T AF by themselves exhib-
ited noT-cell growth factor activity, both ETAF prep-
arations enhanced Interleukin 2 production by cultured 
human peripheral blood lymphocytes when stimulated 
with polyclonal T-cells stimulants (Concanavalin A and 
phorbol myristate acetate). H uman ETAF also was 
chemotactic for rabbit polymorphonuclear le ukocytes 
and was directly mitogenic for cultured human dermal 
fibroblasts. Injection of human ET AF into C3H/HeJ 
mice, r esulted in inducing serum amyloid A (SAA) p r o-
duct ion by murine hepatocytes. The th y mocyte growth-
enhancing activity, the fibroblast- stimula ting act iv ity, 
a nd the S AA-inducing capacity of E T AF all coeluted off 
AcA5 4 gel. These biologic as well as biochemical prop-
erties of huma n keratinocyte-derived ET AF are identi -
cal with those of human macrophage-derived Interleu-
kin 1. T he ability of keratinocytes to release an immu-
nomodulating factor with such diverse consequences 
may play a n important r ole in normal wound healing 
and in diseases involving epithelial tissues. 
M uri ne epidermal cells in cul ture produce an Interleukin 
1(IL 1)-like cytokine wh ich greatly enha nces t he growt h of 
t hymocytes [1,2]. Because of simila ri t ies between certa in mac-
rophages a nd t he Langerhans ce lls (LC) of t he skin , it was 
hypothesized t hat L C-like macrophages produce nonspec ific 
immunoregulato ry cytokines such as IL 1. However, when 
Manuscript received August 2, 1982; accepted for publication Janu · 
ary 4, 1983. 
* Dr. T . A. Luger is on leave from the 2nd Department of Dermatol-
ogy, University of Vienna, Austria. Dr. G. Grabner is on leave from the 
2nd Department of Ophthalmology, Univers ity of Vienna, Austria. Dr. 
T . A. Luger and Dr. G. Grabner are recipients of a Max Kade Foun -
dation Fellowship. 
Rep rin t requests to: Dr. T homas A. Luge r, 2nd Department of 
Dermatology, Universitiit Wien, 4 Alserst rasse, A-1090 Vienna, Aus-
t ria. 
Abbreviations: 
BSS: balanced sal t solution 
CETAF: corneal epi thelial cell thymocyte-activating factor 
Con-A: concanavalin A 
EC: epidermal cell (s) 
epidermal cell (EC) cult ures were treated with an t i Ia -ant i-
:>e rullt end complement to remove LC, t he supernatant st ill 
contained significant levels of thymocyte growth-promoting 
capacity [2], indicating that keratinocytes, the predominan t 
cell type wi t hin t he epidermis, a re the source of E C-derived 
t hymocyte-activating factor (ETAF) . This hormone-like factor 
is produced not only by fresh isolated murine E C in cul ture 
[2,3 ], but a lso by a spontaneously t rans formed BALB/c mouse-
derived keratinocyte cell line (Pa m 212) as well as severa l other 
P a m cell lines [1 ,3 ]. Murine ETAF was biochemically indistin -
guishable from murine macrophage-derived IL 1 in t hat both 
have t he same M, of 15,000, t he same isoelectric point (pi) of 
5.2, a nd are equally stable to pH a nd tempera ture changes 
[1 ,4). ET AF a nd IL 1 a lso have t he same biologic activi t ies, 
i.e., they both enhance t he growt h of t hymocytes, induce Inter -
leu kin 2 (IL 2) production by T cell s [1], and stimulate fibro-
blast proliferation [4] and serum amyloid A (SAA) production 
[5]. This suggests that murine epithelia l cell derived ETAF and 
murine macrophage-derived IL 1 may be identica l. Therefore 
E C of murine origin can potent ially exe rt nonspecific immu -
noregu latory functions in vit ro through t he ir production of 
ETAF. 
In t his study we investigated whether cul tured normal human 
EC and huma n malignant ke ratinocyte cell lines can produce 
E TAF . T he relationship of human IL 1 to human ETAF derived 
from either fresh isolated ke ratinocytes or from maligna nt 
keratinocytes will a lso be cons idered . 
MATERIALS AND METHODS 
Med1:u.m 
Medium 199 containing 100 U/ ml peni cillin , 100 pg/ ml streptomy-
cin , and 0.25 pg/ml fungizone (G rand Island Biological Co., Grand 
Island, New York), supplemented with 7.5% fetal calf serum (FCS) 
(1-l yc lone Sterile Systems, Inc., Logan, Utah) was used as culture 
medium for keratinocytes and the squamous cell carcinoma (SCC) cell 
line. For the thymocyte bioassays RPM! 1640 medium (G rand Island 
Biological Co.) containing 50 pg/ ml Garamycin (Schering Co., Kenil -
worth, New Jersey) and 5% FCS was used. 
ETAF: epidermal cell -derived t hymocyte-activating facto r 
FCS: fe tal calf serum 
IL 1: ln terleuk in 1 
fL 2: lnterleu kin 2 
LC: Langerhans cell (s) 
LPS: lipopolysaccharide 
PB L: peripheral blood lymphocyt.e(s) 
PBS: phosphate-buffered saline 
PHA: phytohemagglutinin 
p i : isoelectric point(s) 
PMA: phorbol myristate acetate 
PMN L: po lymorphonu lear leukocyte(s) 
SAA: serum amyloid A 
SCC: squamous cell carcinoma 
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Epidermal Cell Cultures 
EC cultures contain ing keratinocytes, LC, and melanocytes were 
prepared from human neonatal foreskins, which were obtained by 
routine circumcision according to t he method of Hawley-Nelson et al 
[6]. Briefly, the t issue was floated over 0.25 % trypsin on a sterile filter 
paper. After 18- 26 h the epidermis was separated from the dermis, 
minced, and sti rred at room temperature in calcium - and magnesium-
free phosphate-buffered saline (PBS) in order to dissociate epidermal 
sheets into single ce lls. After 30 min , FCS was added to a final 
concentration of 10% and t he suspension was filtered t hrough nylon 
gauze (Nytex 157 mesh) to remove the stratum corneum . The filtered 
suspension was then centrifuged for 5 min at 250 g and the pelleted 
cells were resuspended in cultu re medium, counted, and diluted to a 
plating density of 1 x 105 ce lls/cm2 in 75 cm2 t issue culture flasks 
(Costar, Cambridge, Massachusetts). The cell viability was > 85% as 
determined by t rypan blue exclusion. The cells were incubated at 37' C 
in 5% C02-containing atmosphere. After 2- 4 days supernatants were 
harvested and stored frozen at 20 ' C before bioassay. 
Squamous Cell Carcinoma Cell Line (SCC 15) 
The SCC cell line was established from a squamous cell carcinoma 
and was kindly provided by Dr. James G. Rheinwald (Division of Cell 
Growth and Regulation, Sidney Farber Cancer Institute, Harvard Med-
ical School, Boston, Massachusetts [7]). The cells were maintained in 
monolayer culture without the support of a feeder layer as previously 
described [7,8). Although t hese SCC cells are the malignant variant of 
keratinocytes, they have been shown to retain keratinocyte-specific 
antigens by indirect immunofluorescence [7). Furthermore, consistent 
with the ir epithelial origin, they contained the 4 major keratins (M, 
46,000, 50,000, 56,000, and 58,000) found in normal keratinocytes [9) . 
In order to subculture the cells they were first washed with PBS (pH 
7. 3) and then treated with 0.05 % trypsin in 0.1 % ethylenediaminote-
tracetic acid at 37' C for 10 min. The detached cells were washed with 
Medium 199, counted with a hemocytometer, and plated at a density 
of 1 X 105 ce lls/cm2 in 75 cm2 tissue culture f1asks (viability> 90% by 
trypan blue exclusion) in Medium 199 with or without 7.5% FCS. 
Supernatants were ha rvested as described above. 
Preparation of Partially Purified lnterleuhin 7 
IL !-containing supernatants were prepared by incubation of human 
adherent cells from huffy coats in the presence of 50 ILg/m l lipopoly-
saccharide (LPS: E. coli 055:B5, Difco Laboratories, Detroit, Michigan) 
and 50 ILg/ml silica (Sigma, St. Louis, Missouri). The supernatants 
were concentrated 25x and subjected to AcA54 gel filtration as de-
scribed previously [1]. Fractions positive for t he biologic activity were 
pooled, filter steri lized, and stored frozen. 
Bioassay for ETAF Activity 
. The enhancement of mitogen-stimulated C3H/HeJ (H-2k) (Jackson 
Labs, Bar Harbor, Maine) mouse thymocyte proliferation was used for 
t he detect ion of ETAF activity as previously described [1] . Brief1y, 
thymocytes in suspension culture were incubated for 3 days at 1.5 x 
106 ce lls/well in microculture plates in the presence of 1 ILg/ml phyto-
hemaggluti nin (PHA) and various dilutions of ETAF. In order to 
quantitate the degree of DNA synthesis, cultures were pulsed with 
['H]-dThd (0.5 ILCi per well) for the final 6 h of incubation. Cells were 
collected using an automatic harvester and the radioactivity was deter-
mined in a liquid scintillation counter. In order to have a more reliable 
index of ETAF activity, uni ts of ETAF activity were established as 
described previously [4]: 
reciprocal titer of test sample at 
30% maximal cpm of standard 
. . X 100 = units/ml sample 
rec1procal titer at 30% of maximal 
cpm of standard 
Biologic assay for IL 2: Supernatants and pooled column fractions 
were also tested for thei r ab ili ty to maintain the growt h of the IL 2-
dependent C57BL/6 mouse-derived T cell line (CT6 cells) [10). The 
cells were washed twice with RPMI 1640 medium and adjusted to a 
density of 1 X 105 ce lls/ml in RPMI 1640 medium containi ng 5% FCS. 
One X 10' cel ls/well were incubated at 37' C in 5% C02 for 24 h with 
various concentrations of test samples and the CT6 cells were pulsed 
for the fina l 6 h and harvested as described [1]. The activity of IL 2 
was also expressed in units as previously described [11]. 
Human peripheral blood lymphocytes (PEL): Human PBL were pre-
pared from huffy coats (kindly provided by the NIH Clinical Center 
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blood bank) by Ficoll-Hypaque gradient sepa ration. This preparation, 
containing T cells, monocytes, and non-T cells, was washed in RPMI 
1640 medium and the PBL were cultured in 1 ml cultures at 1 X 106 
ce ll s with 5 ILg/ml concanavalin A (Con-A) and 5 ng/ml phorbol 
myristate acetate (PMA) in the presence of different concentrations of 
ETAF. The addition of PMA to mitogen-stimulated PBL cultures has 
recently been shown to augment IL 2 production [11] . After 48-h 
incubation at 37' C in 5% C02, t he supernatants were harvested and 
tested for their IL 2 activity as described above. 
Chemotaxis assay: To assay t he chemotactic activity of SCC-ETAF, 
a modified Boyden's chemotaxis chamber (Bio-Rad Laboratories, Rich-
mond, Californ ia) was used [12] . The lower compartment of t he cham-
ber was filled with 0 2 ml of SCC-ETAF or Ill. Both SCC-ETAF and 
IL 1 were generated under serum -free conditions. 
To obtain a suspension of polymorphonuclear leukocytes (PMNL), 
normal adult rabbits were injected i.p. with 100 ml 0.1 % shellfish 
glycogen in saline, and the peritoneal exudate was collected 3 h later. 
Cells in t he exudate were then collected, washed 3 t imes, and resus-
pended in Gey's balanced salt solution (BSS) . This ce ll suspension has 
previously been described to contain an average of 97.6% PMNL [13]. 
A quantity of 0.15 ml of this PMNL suspension in Gey's BSS (contain-
ing 1 X 106 ce lls) was placed in the upper compartment. In this assay 
a 1.2-ILm cellulose acetate filter was used (Millipore Corp. , Bedford, 
Massachusetts). The chamber was incubated for 90 min at 37' C at an 
atmosphere of 5% C02 and 95% air. The filter was then fixed, stained, 
cleared, and mounted on a slide as outlined by Boyden [12]. 
In each test, positive controls (C5 fragments generated in fresh 
rabbit serum by incubating with zymosan) and negative controls (PBS) 
were run at the same time. Before testing for chemotaxis, all samples 
were dialyzed for 24 h using dialysis bags with a M, cut-off at 10,000 
against PBS. 
To quantitate t he chemotactic activity, t he distance of migration 
from the top of the filter toward the leading front of the PMNL 
migrating in the filter was measured in micrometers (when magnified 
300x), as outlined by Zigmond and Hirsch [14]. Five to ten random 
fields were used to quantitate the chemotactic activity of the specimens. 
Fibroblast proliferation assay: The effect of ETAF on fibroblast 
proliferation was tested as described previously [15] . Briefly, human 
dermal fibroblasts (CRL 1445) at a density of 5 x 103 cells were cultured 
in microtiter wells in the presence of different dilutions of ETAF 
preparations. After 48-h incubation at 37 ' C in humidified 5% C02-
containing atmosphere, the cells were pulsed with 1 ILCi of ["H]dThd. 
After a 16-h additional incubation, the fibroblasts were treated with a 
trypsin EDTA solution (0.5 ILg/ml trypsin , 0.2 g/ml EDTA) for 10 min 
and ha rvested using an automatic harvester. The radioactivity was 
determined in a liquid scintillation counter and the results are ex-
pressed as the a ri thmetic mean of cpm of ["H]dThd incorporation by 
triplicate cultures. 
SAA measurements: The concent ration of SAA was measured by 
means of a solid phase radioimmunoassay as described earlier [16,17] . 
Serum was obtained from C3H/HeJ mice 18 h after i.p. injection of 1 
ml of different ETAF preparations., The level of SAA was estimated by 
the capacity to compete with [125I]AA for binding of immobilized anti-
AA antibodies [17]. A standard SAA inducer (STD) was prepared by 
LPS stimu lation of thioglycolate-induced C3H/HeN peritoneal adher-
ent ce ll cultures, as described [17] . This SAA STD was injected into 
C3H/HeJ mice as a positive control of SAA induction. 
Biochemical Characterization of ETAF 
Concentration of supernatants: Supernatants from fresh isolated EC 
cultures as well as from SCC cultures were concentrated using Amicon 
ultrafi ltration cells with UM-10 Diaflo membranes (Amicon Corpora-
t ion, Lexington, Massachusetts). The concentrated materials were then 
used for the procedures described below. 
Gel {iltrat1:on: All biochemical manipulations were carried out at 4 ' C. 
Columns were equilibrated in 50 mM Tris-bufTered 100 mM NaCl (pH 
6.0) with 50 ILg/ml Garamycin. Two mililiters of 25-fold concentrated 
EC or SCC supernatants was applied to a 2.5 x 95 em Sephadex G-75 
column (Pharmacia Fine Chemicals, Piscataway, New J ersey) or to a 
2.5 X 90 em AcA54 column (LKB, Bromma, Sweden) using reverse 
flow. Both columns were calibrated using the following molecular 
markers: bovine serum albumin (M, 67,000), ovalbumin (M, 45,000) , 
chymotrypsinogen A (M, 25,000), and Ribonuclease A (M, 13,700). A 
flow rate of 20 ml/h was used and 3-ml fractions were collected. Aliquots 
of these fractions were t hen diluted 1:2 with 10% FCS containing 
RPM! 1640 medium, filter sterilized, and tested for ETAF activity. 
Fractions positive for t he biologic activi ty were pooled and stored at 
-20'C. 
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Chromatofocu.sing: In order to determine t he pi a nd for further 
purification of ETAF, t he pooled activity of EC-ETAF or SCC-ETAF 
eluted off G-75 gel filtration was chromatofocused as described by 
S luytermann and Wijdenes [18,19]. Twenty-five milliliters of polybuf-
fer exchanger PBE 94 (Pharmacia Fine Chemica ls) was equilibrated in 
0.025 M imidazole HCl buffer (pH 7.4) in a 1 X 30 em column. One 
hundred milliliters of different ETAF preparations were dia lyzed 
against the same 0.025 M imidazole HCl bu ffer a nd t hen applied to t he 
column at a now rate of 20 ml / h using polybuffer 74- HCl at pH 4.0 
(Pharmacia Fine Chemicals). Fractions of 1 ml were collected a nd 
aliquots were prepared for t he bioassay as described above. 
pH treatment: The pH stability of partially purified EC-ETAF or 
SCC-ETAF (pooled activ ity off G-75 gel fi ltration ) was determined by 
dialyzing these fo r 24 h with dialysis bags wit h a M, cut-off at 10,000 
against 0.15 M buffer ranging from pH 2- 13 as described previously 
[1]. 
Protein determination: Protein determinations were carried out by 
t he Coomass ie Blue dye method [20]. Samples (100 Ill) were mixed 
wit h 1 ml of reagent a nd the absorbance at 595 nm was determined. 
RESULTS 
Cell Sources of Human ETAF Activity 
Supernatants of freshly isolated human keratinocytes were 
tested for t heir thymocyte growth-enhancing capacity. These 
FIG 1. Gel filtration on Seph-
adex G-75 of 25X concentrated 
supernatants of fresh isolated EC 
(A) as well as of a SCC cell line 
(B). Fractions were tested at dif-
ferent dilutions in the thymocyte 
assay and t he ETAF activity was 
expressed in uni ts/m l as de-
scribed. 
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supernatants significant ly enhanced the proliferation of PHA-
stimulated C3H/HeJ t hymocytes. Supernatants of a SCC cell 
line also contained thymocyte growth-costimulating activity. 
However, when plated at t he same cell density of 1 X 106 cells/ 
ml, more ET AF activity appeared in supernatants of freshly 
isolated EC cul tures (EC-ETAF) t han in supernatants of SCC 
ce ll cultures (SCC-ETAF) (data not shown) . These findings 
indicate t hat human EC and to a lesser extent human SCC cell 
line cells produce ETAF activity. Other human cells tested for 
production of ETAF, such as human dermal fibroblasts and 
human cul tures derived from epidermal primaries treated with 
PMA (21], were negative (data not shown). 
Biochemical Characterization of Human ETAF 
Cul.ture supernatants from fresh isolated EC as well as from 
t he SCC cell line were concentrated 25X by UM-10 Amicon 
ultrafiltration. These concentrated samples were then subjected 
to gel fi ltration on Sephadex G-75. ETAF activity derived from 
fresh isolated EC supernatants (EC-ETAF) eluted as a major 
peak at aM, range of 30,000-12,000 (Fig 1A). ETAF activity 
produced by SCC cell line cells (SCC-ETAF) eluted as a single 
peak t hat exhibited a M, of 15,000 (Fig. 1B). 
Subsequently, those G-75 gel fi ltration fract ions ofEC-ETAF 
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(effluent volume 240-400) and SCC-ETAF (eff1uent volume 
350-400) containing ETAF activity were pooled and subjected 
to chromatofocusing. Applying a linear pH gradient from pH 
7.4-4.0, the ETAF activity from fresh isolated EC as well as 
from the sec cell line were eluted as 3 major peaks at pi 7.2 
(a-ETAF), 5.8 (/3-ETAF), and 5.0 (-y-ETAF) (Fig 2A,B). 
When partially purified EC-ET AF (pooled activity off G-75 
gel filtration) and SCC-ETAF (pooled activity off G-75 gel 
fi ltration) were tested for pH stabi lity, the activity was stable 
from pH 4-12 (Table I). An acid pH of 3 and below and a lkaline 
pH of 13 clearly inactivated both EC-ETAF and SCC-ETAF 
activity. Additionally, both of the ETAF activities were stable 
when dialyzed against low-ionic-strength buffers or distilled 
water (data not shown). 
Both EC-ETAF and SCC-ETAF remained active when 
treated for 2 h at 56°C, and were clearly inactivated within 10 
min at 800C or lOOoC (Table II) . However, when treated for 1 
h at lOOOC, 91 % of EC-ETAF activity was destroyed, whereas 
only 74% of SCC-ETAF activity was inactivated, suggesting 
there may be different species of ETAF activity. 
The results of these preliminary purifications of EC-ETAF 
and SCC-ETAF are summarized in Table III. The starting 
material of both of the ET AF preparations had a sp act of 
approximately 37 units/mi. After G-75 filtration the yield was 
actually increased by about 15%, perhaps due to the removal 
of an inhibitory factor present in the crude supernatants. 
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FIG 2. Chromatofocusing of the pooled G-75 gel filtration contain-
ine ETAF activity from fresh isolated EC cultures (A) and ETAF from 
the SCC cell line (B). The pH of the fractions was measured using an 
electrode and the ETAF activity was determined by the thymocyte 
assay. The activity was expressed in units/ml as described. 
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TABLE I. pH Stability of ETAF 
EC-ETAF SCC-ETAF 
pH Treatment 
U/ml % U/ml % 
118" 100 192 100 
2 7 6 0 0 
3 8 7 0 0 
4 68 58 79 39 
5 87 74 154 80 
6 65 55 150 78 
7 89 75 96 50 
8 62 53 90 47 
9 67 57 102 63 
10 86 73 112 58 
11 85 72 106 55 
12 38 33 138 72 
13 15 13 73 38 
• Units/ml ETAF activity (pooled activ ity elu ted from G-75 filtra · 
t ion). 
TABLE II. T emperature stability of ETAF 
Trea· Temperature 
tment 
time 37' C 56' C 80' C lOO' C 
EC 10 108" (92)b 105 (89) 31 (26) 8 (7) 
ETAF 30 96 (81) 80 (68) 25 (21) 10 (8) 
60 87 (74) 78 (66) 17 (14) 13 (11) 
sec 10 195 (102)' 182 (95) 84 (44) 52 (27) 
ETAF 30 188 (98) 186 (96) 50 (26) 48 (25) 
60 196 (102) 161 (84) 57 (29) ~1.(26) 
• Units/m l ETAF activity. \ 
b Percent ofETAF activity compared to non treated partially purified 
EC-ETAF (pool elu ted from G-75 filtration, 118 U/m l). \ 
' Percent of ETAF activity compa red to non treated partially purified 
SCC-ETAF (pool eluted from G-75 fi ltration, 192 U/m l). 
Following chromatofocusing, the samples positive for ETAF 
activity contained< 0.001 g protein, thus increasing the sp act 
further to at least 75,000 units/ mi. 
Effects of ETAF on Peripheral Lymphocytes 
We addressed the question of whether human ETAF like IL 
1 affects peripheralized immunocompetent lymphocytes. Nei-
ther EC-ETAF nor SCC-ETAF showed a direct mitogenic 
effect on human peripheral lymphocytes (data not shown). 
However, when human PBL were stimulated with Con-A and 
PMA in the presence of added doses of EC-ETAF or SCC-
ETAF (pooled activity off the G-75 gel filtration), significantly 
increased IL 2 activity was produced by these PBL cultures 
(Table IV). The degree of stimulation of IL 2 activity was 
directly proportional to the units of ETAF added to t he cul-
tures. SCC-ETAF, when used at lower concentrations of 10 or 
5 U/11l was more potent in enhancing IL 2 production than EC-
ETAF. None of the preparations of human ETAF by itself was 
able to induce IL 2 activity and none had a direct effect on t he 
growth of the II 2-dependent murine T cell line CT6 (data not 
shown). 
Chemotactic Activity of ETAF and IL 1 
Serum-free supernatants of the SCC cell line cells and cul-
tured human peripheral adherent cells as well as partially 
purified SCC-ETAF and IL 1 (pooled activity off AcA54 gel 
fil tration) were tested in the thymocyte costimulato r assay and 
their activity expressed in units/ml as described. Subsequently, 
the same proportions were diluted with PBS, dialyzed against 
PBS, and tested at a concentration of 20 U/ml for their chem-
otactic effect on rabbit peritoneal PMN ce lls. As is the case 
with a simi lar mediator, corneal epithelial cell thymocyte-
activating factor (CETAF) [22] ETAF as well as 11 !-contain-
ing fractions were chemotactic for PMNL when compared to 
the diluent (PBS) (Table V). Control experiments indicated 
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TABLE Ill. Sequential purification of ETAF 
Amount (ml) Protein (J.Lg) 
Purification step 
EC" sec• EC sec 
Crude supernatant 100 100 201 175 
Amicon UM-10 5 5 132 120 
Sephadex G-75 90 39 1.8 0.85 
Chromatofocusing: 
a 40 18 < 0.001 <0.001 
(3 25 25 < 0.001 < 0.001 
-y 30 30 <0.001 <0.001 
"Epidermal cells, supernatant (fresh isolated). 
b sec cell line supernatant. 
TABLE IV . Enhanced IL 2 production by human PBL stimulated with 
EC-ETAF and SCC-ETAF 
EC-ETAF 
SCC-ETAF 
0 
164 ± 12" 
211 ± 22 
ETAF (U/ml) 
20 10 5 
464±60 279±48 214±6 
435 ± 32 449 ± 39 393 ± 10 
a Un its of IL 2 activity, mean ± SE of 3 different experiments. PBL 
(1 x 106/mll were incubated 48 h in t he presence of 5 !Lg/ ml Con-A 
and 5 ng/ml PMA. ETAF a lone without added Con-A+ PMA was not 
able to induce IL 2 activity. 
TABLE V. Chemotactic activity of ETAF and IL I 
ETAF (20 U/ mll IL 1 (20 U/ml) 
Crude supernatant 
Pooled activity off 
AcA54 gel 
48 ± 2" 
57± 3 
50± 2 
49 ± 2 
a The resu lts are expressed as mean ± SE of migration in !Lm of 5 
ra ndom fields in 2 experiments. The background chemotactic activity 
of PMN leukocytes in PBS, without added sample was 32 ± 3 J.Lm. 
Zymosan-treated rabbit serum, used as a positive control , exhibited a 
chemotactic effect of 130 ± 9 JLm . The chemotactic activity of all 
samples tested was significa ntly (p < 0.001) increased when compared 
to the negative cont rol (Student's t-test) . 
t hat the increased migration of PMNL is due to chemoattrac-
t ive effects of IL 1, ETAF, or CETAF [22], rather than merely 
to increased chemokinetic activity. 
Effect of ETAF on Noninflammatory Cells 
There are many recent observations indicating that IL 1 as 
well as closely related factors act not only on lymphocytes but 
on a wide variety of other target cells [23,24] . Because· of the 
similar characteristics of human ET AF and human IL 1, we 
raised the question of whether human ETAF also would affect 
noninflammatory cells. Therefore, column fractions of an 
AcA54 gel filtration of 25x concentrated SCC cell line super-
natants were tested for their thymocyte growth-enhancing ca-
pacity as well as for their fibroblast growth-promoting effects. 
Both activities were recovered in one major peak at a M, range 
of 25,000-10,000, suggesting that the fibroblast-stimulating and 
the thymocyte growth-enhancing effects of ETAF coelute on 
gel filtration (Fig 3). 
Furthermore, we were interested in determining whether 
ET AF also has some in vivo functions. Therefore, aliquots of 
column fractions of t he above-mentioned AcA54 gel filtration 
were pooled and 5 different pools were injected into mice to 
test for their SAA-inducing capacity. Only t he pools containing 
ETAF activity also induced SAA production (Fig 3). These 
results indicate that ETAF, besides it effect on thymocytes, 
also stimulates fibroblasts in culture and induces SAA produc-
tion by hepatocytes in vivo. 
DISCUSSION 
ETAF activity was produced constitut ively in vitro by cu l-
tures of freshly isolated heterogeneous murine and human EC. 
Elimination of murine macrophage-like LC by treatment with 
Units of ETAF Specific activity (U/ J.Lg) Yield 
EC sec EC sec EC sec 
7,690 6,500 37.3 37.1 100 100 
5,960 5,075 45.7 42.3 80 78 
8,730 7,315 4,850 6,606 117 11 2 
1,600 1,620 > 180,000 > 180,000 21 25 
750 2,080 >75,000 >208,000 10 32 
900 1,620 >90,000 > 180,000 12 28 
anti-Ia antiserum and complement, did not decrease ETAF 
production, suggesting, that keratinocytes were the main source 
of ETAF activity [2]. In addition, LC-free human keratinocyte 
cell lines (SCC) also produced a similar mediator. However, for 
an unknown reason SCC cells produced lower levels of ET AF 
activity on a per cell basis than fres hly isolated kerat inocytes. 
In order to characterize and differentiate ETAF activity 
produced by normal as well as malignant keratinocytes, the 
biochemical properties of EC-ETAF and SCC-ETAF were com-
pared using · ge l fi ltration as a first step of purification. The 
increased yield of ETAF activity after gel filtration suggests 
the presence of an inhibitor in the keratinocyte supernatants. 
Both EC-ETAF and SCC-ETAF eluted within a similar M, 
range of 12,000-25,000 from gel fi ltration, exhibited t he same 
3 pi of 7.2, 5.8, and 5.0 and their temperature and pH stability 
were simi lar. However there are two minor differences as fol-
lows: SCC-ETAF seems to be slightly less heat labile t han EC-
ETAF, suggesting that SCC cells may release more of a tem-
perature-stable species of ETAF. In addition, ETAF produced 
by normal EC was more heterogenous in M, than the SCC cell -
derived ETAF. Perhap this is due to the greater heterogeneity 
of keratinocytes present in freshly isolated EC cultures, which 
may produce several different thymocyte growth -enhancing 
activities. Furthermore, it has not yet been determined whether 
or not other cells within the epidermis such as LC or melano-
cytes also have the capacity to produce an IL 1-like thymocyte-
activating factor. Alternatively, the fresh epithelial cells which 
are less viable than the cell line ce lls, may release intracellular 
variants of ETAF or enzymes t hat can partially degrade ETAF. 
The above biochemical properties of human ETAF are sim-
ilar to those of human IL 1 in that ETAF as well as lL 1 have 
the same M, and a simila r pH and temperature stabili ty 
[23,24]. Although human ETAF like human IL 1 has ident ical 
pi's [25], it is not yet established whether this charge hetero-
geneity may be due to posttranslational glycosylation as has 
been described for IL 2 [26]. Neither human IL 1 nor human 
ET AF have been purified to homogeneity and only furt her 
biochemical characterization and amino acid sequencing will 
conclusively reveal whether the multiplicity of biologic prop-
erties of ET AF and IL 1 are due to the same or different 
moieties. 
A number of intriguing biologic functions can be ascribed to 
ETAF. Partially purified human ETAF enhances the IL 2 
production of lectin-stimulated human PBL and murine spleen 
cell cultures (data not shown) , is mitogenic for human dermal 
fibroblasts , induces SAA production by murine hepatocytes, 
and is chemotactic for rabbi t PMNL. One of the most impor-
tant functions of IL 1 is to promote T -lymphocyte production 
of lymphokines such as lymphocyte-derived chemotactic factor 
[25] and IL 2 [27,28] and to increase t he activity ofT helper 
cells, which results in greater production of antibodies by B 
lymphocytes in response to T cell dependent stimuli [29-31]. 
As is the case wit h IL 1, human ETAF enhanced the production 
of IL 2 by cultures of human PBL t hat were concomitantly 
stimulated with optimal doses of Con-A and PMA. The capacity 
of ETAF to enhance IL 2 production is of importance because 
IL 2 has been demonstrated to play an important role in the 
ampli fication of immune responses [32-36]. In contrast, human 
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ETAF-like murine ETAF [1) had no direct effect on human 
PBL nor on the IL 2-dependent CT6 cell line, and therefore 
exhibits no IL 2 activities by itself. · 
It has recently been shown that the thymocyte proliferation 
activity of IL 1 coelutes with the fibroblast proliferation activity 
upon gel filtration and subsequent isoelectrofocusing [15). Sim-
ilarly, ETAF exhibited both of these activities and they coeluted 
upon gel filtration. The SAA inducer activity of ETAF also 
eluted within the same M, range as the thymocyte and fibro-
blast growth-promoting activity. Although it is not yet fully 
elucidated whether ETAF and SAA inducers are completely 
identical, it is noteworthy that keratinocytes produce a media-
tor(s) that stimulates in vivo hepatocyte production of acute 
phase reactants such as SAA. SAA has been proposed as the 
circulating precursor of AA fibrils which are found in amyloid 
deposits in tissues of the liver, kidney, skin, etc. secondary to 
chronic inflammation [5,37]. Thus increased ETAF production 
may be involved in the formation of amyloid deposits in sys-
temic and cutaneous amyloidosis. 
Presumably EC injury results in stimulation of ETAF pro-
duction [ 4) which can activate many target cells as described. 
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FIG 3. AcA54 gel fi ltration of ETAF 
activity in 25X concentrated SCC cell 
line supernatants. Fractions were tested 
at different di lutions in thymocyte assay 
(A) and the fibroblast stimulation assay 
(B). ETAF activity is expressed in units/ 
ml, whereas the fibrobl ast stimulation is 
represented as D. cpm at a sample di lu-
tion of 1:4. Furthermore, the same col-
umn fractions were pooled and tested for 
their SAA inducer capacity (C). LPS 
induced 1.8 ± 0.1 11 g SAA/ml whereas 
the STD SAA inducer preparation in · 
duced 16.56 ± 0.1 11g SAA/ml. 
How~ver, it is not yet clear how far ETAF can diffuse into the 
surrounding tissues and how long this mediator can remain 
active. Therefore we investigated whether any mediator, in 
addition to its activating effects, actually attracted int1amma-
tory cells as well. It was determined that ETAF-containing 
fractions and IL 1 can attract both rabbit and human PMNL 
[38). The chemotactic activity cannot be attributed to contam-
inating endotoxin or serum protein such C3a and C5a anaphy-
latoxins [39,40) since ETAF and IL 1 were generated under 
serum-free conditions and endotoxin could release C5a only in 
the presence of serum [ 40,41]. Although this chemotactic effect 
was demonstrated in vitro it might have important implications 
in skin diseases, such as psoriasis where there is increased 
mitotic activity of EC associated with an infiltration consisting 
main ly of PMNL [38). Therefore, as is the case with murine 
keratinocytes [4), human EC as well may respond to injury or 
other provocative stimuli with increased ETAF production, 
which in turn would attract PMNL. Whether ETAF is also 
chemotactic for other cell types such as monocytes or fibro-
blasts, remains to be ascertained. 
The described biologic and biochemical properties of ETAF 
Sept. 1983 
indicate that similar immunoen hancing activities are produced 
by a variety of normal as well as transformed keratinocytes and 
may reside in a single factor known as IL 1. In addition, 
mediators such as ETAF or IL 1 cross species barriers and are 
not genetically restricted. Furthermore, there is some evidence 
that not on ly EC of human as well as of murine origin produce 
a n immunoEmhancing factor, but also epithelial cells from 
different sites such as t he oral mucosa [3], cornea [ 42], and 
t hymus [ 43) do also. Therefore, epithelial cells in general might 
be able to respond with the production of an IL 1-like signal 
and thereby augment immune and inf1ammatory response as 
well as stimulate and/or attract a variety of target cells. 
The aut hors wish to t hank Dr. J. Oh for his techn ical advice with 
the chemotaxis assay; Drs. I. Gree n, S. I. Katz, and T . Kra kauer for 
their critical discussion of this ma nuscript; a nd Mrs. Carrie McGahey 
for her expert secretarial assistance. 
REFERENCES 
1. Luger TA, Stadler BM , Katz SI, Oppenheim JJ : Epidermal cell 
(kerat inocyte) derived t hymocyte activating factor (ETAF). J 
Immunol 127:1493-1498, 1981 
2. Sauder ON, Carter C, Katz SI, Oppenheim JJ: Epidermal cell 
production of t hymocyte activating factor (ETAF). J Invest 
Dermatol 79:34-39, 1982 
3. Luger TA, Oppenheim JJ: Characte ristics of ln terleukin 1 and 
epiderma l cell derived t hymocyte activat ing factor (ETAF) , Ad-
vances in lnf1ammation Research, vol 5. Edited by G Weissman. 
New York, Raven Press, 1983, pp 1-25 
4. Luger TA, Stadler BM, Luger BM, Mathieson BJ , Mage M, 
Schmidt JA , Oppenheim JJ : Murine epidermal cell derived t hy-
mocyte activating factor resembles murine In te rleukin 1. J Im-
munol 128:2 147-2152, 1982 
5. Sztein MB, Luger TA, Oppenheim JJ: An epidermal cell derived 
cytokine t riggers t he in vivo synt hesis of serum amyloid A by 
hepatocytes. J lmmunol 129:87- 90, 1982 
6. Hawley-Nelson P, Su llivan JE, Kung M, Hennings H , Yuspa SH: 
Optimized conditions for the growth of huma n epidermal cells 
in culture. J Invest Dermatol 75:176-187, 1980 
7. Rheinwald JG , Beckett MA: Defective termina l different iation in 
culture as a consistent and selectable cha racte r of malignant 
huma n keratinocytes. Cell 22:629-632, 1980 
8. Rheinwa ld JG, Beckett MA: Tumorigenic keratinocyte lines re-
quiring anchorage and fibroblast support cultured from human 
squamous cell carci nomas. Cell Res 41:1657- 1663, 1981 
9. Ying-Jye Wu, Rheinwald JG: A new small (40 kd) kerat in filament 
protein made by some cul tured human squa mous cell carcinomas. 
Cell 25:627-635, 1981 
10. Watson I, Gillis S, Marbrook J , Mochizuki D, Smith KA: Biochem-
ical and biological characterization of lymphocyte regulatory 
molecules. I. J ustification of a class of murine lymphokines. J 
Exp Med 150:849-855, 1979 
11. Stadler BM, Dougherty SA, Farrar JJ , Oppenheim JJ: Relationship 
of cel l cycle to recovery of IL 2 activity from human mononuclear 
cells, human and mouse T cell lines. J lmmunol 127:1 936- 1940, 
1981 
12. Boyden S: The chemotactic effect of a mixture of ant ibody and 
antigen to polymorphonuclear leukocytes. J Exp Med 115:454-
462, 1962 
13. Oh JO, Kopal MA: Chemotactic activity and cellular infiltration 
of aqueous humor in experimental herpes simplex uveitis. Invest 
Ophtha lmol Vis Sci 18:206- 210, 1979 
14. Zigmond SM, Hirsch JG: Leucocyte locomotion and chemotaxis: 
new methods for evaluation a nd demonstration of a cell derived 
chemotactic factor. J Exp Med 137:387-395, 1973 
15. Schmidt JA , Mize! SB, Cohen D, Green I: ln terleukin 1, a potent ial 
regulato r of fibroblast proliferation . J lmmunol 128:2177-2182, 
1982 
16. Sipe JD, Vogel SN, Rya n JL, McAdam KPWJ , Rosenstreich DL: 
Detection of a mediator derived from endotox in stimulated mac-
rophages t hat induces the acute phase SAA response in mice. J 
Exp Med 150:597-606, 1979 
17. Sztein MB, Vogel SN, Sipe JD, Murphy PA, Mizel SB, Oppenheim 
JJ, Rosenstreich DL: The role of macrophages in the acute phase 
response: SAA inducer is closely related to lymphocyte activat ing 
factor and endogenous pyrogen. Cell Immunol 63: 164- 176, 1981 
18. Sluyterman LA, Wijdenes J: Chromatofocusing: isoelectric focusing 
on ion excha nge columns. I. General principles. J Chromatogr 
150:17-30, 1978 
19. S luyterman LA , Wijdenes J: Chromatofocusing: isoelectr ic focusing 
on ion excha nge columns. II . Experimental veri!ication. J Chro-
CHARACTERISTICS OF HUMAN ETAF 193 
matogr 150:31-44, 1978 
20. Bradford MM: A rapid and sensitive method for t he quan t itation 
of microgra m quantities of protein using t he principle of protein -
dye binding. Anal B iochem 72:248-255, 1976 
21. Hawley-Nelson P , Stan ley JR, Schmidt J, Gullino M, Yuspa SH: 
The tumor promotor 12-0-tetrodecanoylphorbol-13-acetate ac-
celerates keratinocyte differentiation and stimulates growth of 
an un indentified cell type in cultured human epidermis. Exp Cell 
Res 137:155- 167, 1982 
22. Grabner G, Luger TA, Luger BM , Smolin G, Oh JO: Biological 
properties of t he t hymocyte-activating factor (CETAF) produced 
by a rabbi t corneal cell line (SIRC) . Invest Ophthalmol Vis Sci, 
in press, 1983 
23. Oppenheim JJ, Luger TA, Sztein MB, Steeg PS: Circuit of cytokine 
cell in te ractions that regulate immunological and inflammatory 
reactions, Self Defense Mecha nisms: Role of Macrophages. Ed-
ited by D Mizumo, ZA Cohn, K T akeya, N Ishida, Un iversity of 
Tokyo Press, Elsevier, Biomedical 1982, pp 127- 136 
24. OppenHeim JJ , Stadler BM, Siragan ian RP, Mage M , Mathieson 
B: Properties of Interleukin 1 (IL 1). Fed Proc 41:111- 116, 1981 
25 . Mizel SB: Biochemical characterization of macrophage derived 
lymphostimulatory facto rs, T he Lymphokines, Biochemistry and 
Biological Activity. Edited by JW Hadden, WE Stewad III. N.J ., 
Huma na Press, 1981, pp 347- 365 
26. Fa rra r JJ, Mizel SB, Fuller-Fa rra r J , Farrar WL, Hilfiker ML: 
Macrophage-independent activation of helper T cells. I. Produc-
tion of Interleukin 2. J lmmunol125:793- 798, 1980 
27. Larsson EL, Iscove NN, Cout inho A: Two dist inct factors are 
required for induction of T cell growth. Nature 283:664- 666, 
1980 
28. Smith KA, Gilbride KJ, Favata MF: LAF promotes TCGF produc-
t ion by cloned murine lymphoma cells. Nature 287:853- 855, 1980 
29. Fa rra r JJ , Koopma n WJ: Cha racterization of macrophage a nd 
lymphocyte-derived mitogenic factors and t heir effect on t he 
a ntibody response in vitro, Biology of the Lymphokines. Edited 
by S Cohen, E P ick, JJ Oppenheim., New York, Academic Press, 
1979, pp 325-346 
30. Koopma n WJ, Fa rrar JJ , Fuller-Bonar J: Evidence for t he identi -
fication of lymphocyte-activating facto r as the adherent cell -
derived mediato r responsible for enhanced antibody synthesis 
by nude mouse spleen cells. Cell lmmunol 35:92-98, 1978 
31. Watson JL, Aarden A, Shan J , Paetkau V: Molecula r and qua nti -
tative analys is of helper T cell replacing factors on the induction 
of antigen-sensit ive BandT lymphocytes. J Immunol 122: 1633-
1638, 1979 
32. Gi llis S, Smith KA: Long term culture of tumor specific T cells. 
Nature 268:154-158, 1977 
33. Ruscetti FW, Morgan DA, Gallo RC: Functional and morphologic 
characterization of human T cells continuously grown in vitro. 
J lmmunol 119:131- 138, 1977 
34. Farrar JJ, Simon PL, Koopman WJ, Fu ller-Bonar J : Bioc hemical 
relationship of t hymocyte mitogenic factor and factors enhanc-
ing humoral and cell -mediated immune response. J Immunol 
121:1353-1360, 1978 
35. Wagner M, Rii llinghoff M: T-T-cell in teractions in vitro cytotox ic 
allograft responses. I. Soluble products from activated Ly 1 + T 
cells t rigger autonomously antigen-primed Ly 23+ T cells to ce ll 
proliferation and cytolytic activity. J Exp Med 148:1523-1538, 
1978 
36. Farrar WL, J ohnson HM, Fa rra r JJ: Regulation of the production 
of immune interferon and cytotox ic T lymphocytes by lnterleu-
kin 2. J Immunol 126:1120- 1125, 1981 
37. Husby G, Natvig JB: A serum component re lated to non-immu-
noglobin proteins AS, a possible precursor of the fibril. J Clin 
Invest 53:1054- 1061, 1976 
38. Luge r TA, Sztein MB , Charon JA, Oppenheim JJ : Epidermal cell 
thymocyte act(vating factor (ETAF) effects different infla mma-
to ry cells, Interleukins, Lymphokines and Cytokines. Edited by 
JJ Oppenheim, S Cohen. New York, Academic Press, 1983, in 
press 
39. Fernandez MN , Henson PM, Otani A, Hugli TE: Chemotactic 
response to huma n C3a a nd C5a anaphylatoxin. I. Evaluation of 
C3a and C5a leukotaxis in vitro a nd under stimulated in vivo 
conditions. J Immunol 120:109- 115, 1978 
40. Snyderman R, Pike MC, McCarley D, Long L: Quantification of 
mouse macrophage chemotaxis in vitro: ro le of C5 for t he pro-
duction of chemotactic activity. lnfect Immunol11:488- 493, 1975 
41. Verghese MW, Synderman R: Endotoxin (LPS) stimulates in vitro 
migration of macrophages from LPS-resistant but not from LPS-
sensit ive mice. J Immunol 128:608-613, 1982 
42. Grabner G, Luger TA, Smolin G, Oppenheim JJ: Corneal epithelial 
t hymocyte activating factor (CETAF). Invest Ophthalmol Vis 
Sci 23:757- 763, 1982 
43. Kruisbeek AJ , Zijlstra JJ , Kriise TJM: Distinct effects ofT cell 
growt h factors and thym ic epithelial factors in the generation of 
cytotox ic T lymphocytes by thymocyte subpopulations. J Im-
munol 125:995- 1002, 1980 
